Global Cell and Gene Therapy (CGT) Supply Chain Software Markets, 2019-2023 & 2024-2035: Companies Enter Strategic Collaborations to Meet Growing Demand, Opportunities in Expanding Product...
BioLife Solutions, Inc. (BLFS)
Last biolife solutions, inc. earnings: 3/11 04:29 pm
Check Earnings Report
US:NASDAQ Investor Relations:
biolifesolutions.com
Company Research
Source: Yahoo! Finance
Software Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Process Component, Type of Software, Mode of Deployment, Scale of Operation, Type of End-user and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering The global cell and gene therapy (CGT) supply chain software market is projected to grow from $274 million in 2024 to $1,329 million by 2035, representing a CAGR of 15.2%, during the forecast period 2024-2035. This research study consists of industry trends, detailed cell and gene therapy supply chain software market analysis, funding and investment trends, partnerships and collaborations analysis, platform utilization trends, stakeholder needs analysis and market impact analysis. The report includes cell and gene therapy supply chain software market forecast and opportunity analysis. One of the key objectives of this market report was to estimate the current market size, opportunity and the future growth potential of
Show less
Read more
Impact Snapshot
Event Time:
BLFS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLFS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLFS alerts
High impacting BioLife Solutions, Inc. news events
Weekly update
A roundup of the hottest topics
BLFS
News
- BioLife (BLFS) Progresses in Cell & Gene Therapy With CryoCase [Yahoo! Finance]Yahoo! Finance
- BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver [Yahoo! Finance]Yahoo! Finance
- BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in VancouverPR Newswire
- BioLife Solutions, Inc. (NASDAQ: BLFS) was upgraded by analysts at Benchmark Co. from a "neutral" rating to a "buy" rating. They now have a $25.00 price target on the stock.MarketBeat
- Analysts Are Upgrading BioLife Solutions, Inc. (NASDAQ:BLFS) After Its Latest Results [Yahoo! Finance]Yahoo! Finance
BLFS
Earnings
- 5/9/24 - Beat
BLFS
Sec Filings
- 6/5/24 - Form DEF
- 5/31/24 - Form 4
- 5/31/24 - Form 4
- BLFS's page on the SEC website